|
Market Closed -
Nasdaq
05:00:00 11/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 253.25 USD | -0.64% |
|
+1.74% | +43.90% |
| 11-09 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
| 10-30 | Biogen Presents New Data Across Alzheimer?S Disease Portfolio At CTAD 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed | |
Sao Paulo
| BIIB34 | Delayed | |
Buenos Aires S.E.
| BIIB | End-of-day quote | |
|
Buenos Aires S.E.
| BIIBD | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 254.87 | 254.87 | 253.62 |
| Spread/Res. | -0.64% | -0.64% | -0.15% |
| Spread/Supp. | +8.85% | +15.94% | +25.25% |
| Support | 232.65 | 218.43 | 202.19 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
